Loperamide/octreotide/trametinibVarious toxicities and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1960卷 / 1期

关键词：

D O I：

10.1007/s40278-023-41093-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：265 / 265

相关论文

共 50 条

[21] Cabozantinib/dabrafenib/trametinibVarious toxicities: case report
Reactions Weekly, 2020, 1785 (1) : 127 - 127
[22] Dabrafenib/pembrolizumab/trametinibVarious toxicities: case report
Reactions Weekly, 2021, 1886 (1) : 152 - 152
[23] Octreotide/venlafaxineHypoglycaemia and lack of efficacy: case report
Reactions Weekly, 2023, 1976 (1) : 264 - 264
[24] Dabrafenib/pembrolizumab/trametinibVarious toxicities: case report
Reactions Weekly, 2025, 2043 (1) : 127 - 127
[25] Dabrafenib/osimertinib/trametinibVarious toxicities: case report
Reactions Weekly, 2020, 1788 (1) : 86 - 86
[26] Dabrafenib/osimertinib/trametinibVarious toxicities: case report
Reactions Weekly, 2021, 1875 (1) : 114 - 114
[27] Temozolomide/topotecan/trametinibVarious toxicities: case report
Reactions Weekly, 2020, 1790 (1) : 210 - 210
[28] AntineoplasticsVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2023, 1952 (1) : 82 - 82
[29] AntineoplasticsVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2022, 1921 (1) : 42 - 42
[30] AntineoplasticsVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2021, 1850 (1) : 52 - 52

← 1 2 3 4 5 →